SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-21-000145
Filing Date
2021-05-12
Accepted
2021-05-12 07:07:46
Documents
9
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF MAY 2021 imv6kq1.htm 6-K 5962
2 INTERIM FINANCIAL STATEMENTS FOR THE PERIOD ENDED MARCH 31, 2021 exhibit99-1.htm EX-99.1 174598
3 MANAGEMENT DISCUSSION AND ANALYSIS FOR THE PERIOD ENDED MARCH 31, 2021 exhibit99-2.htm EX-99.2 163081
4 CEO CERTIFICATION exhibit99-3.htm EX-99.3 9804
5 CFO CERTIFICATION exhibit99-4.htm EX-99.4 9875
6 exhibit99-1x1x1.jpg GRAPHIC 8527
7 exhibit99-2x1x1.jpg GRAPHIC 6799
8 exhibit99-2x6x1.jpg GRAPHIC 113979
9 exhibit99-2x21x1.jpg GRAPHIC 35979
  Complete submission text file 0001176256-21-000145.txt   592548
Mailing Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4
Business Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4 9024921819
IMV Inc. (Filer) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38480 | Film No.: 21913431
SIC: 2834 Pharmaceutical Preparations